Malamut Richard — SEC Form 4 filings
SEC reporting owner CIK 1772168. 6 Form 4 filings on record with FilingPulse; latest filed 2026-04-06.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-06-18 to 2026-04-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,400 shares, $9,825 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 590 shares, $12,340 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: purchase of 10,400 shares @ $0.94 ($9,825) in Pelthos Therapeutics Inc., filed 2024-09-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | Director | 6 | 1 leg · 10,400 sh · $9,825 | 2 legs · 590 sh · $12,340 | 7 |
Form 4 filings — Malamut Richard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-06 | 4 | Pelthos Therapeutics Inc. (PTHS) | Sale (S): 310 @ $20.51 · Sale (S): 280 @ $21.36 | EDGAR |
| 2026-04-01 | 4/A | Pelthos Therapeutics Inc. (PTHS) | Grant/award (A): 6,450 @ $0 · Grant/award (A): 2,454 @ $0 · Grant/award (A): 19,108 @ $0 | EDGAR |
| 2025-07-07 | 4 | Pelthos Therapeutics Inc. (PTHS) | Grant/award (A): 19,108 (derivative) · Grant/award (A): 58,230 (derivative) | EDGAR |
| 2024-11-15 | 4 | Chromocell Therapeutics Corp (CHRO) | Grant/award (A): 24,533 (derivative) | EDGAR |
| 2024-09-16 | 4 | Chromocell Therapeutics Corp (CHRO) | Purchase (P): 10,400 @ $0.94 | EDGAR |
| 2024-06-18 | 4 | Chromocell Therapeutics Corp (CHRO) | Grant/award (A): 64,498 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1772168 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →